Cardiovascular risk factors in Mexican-American children at risk for type 2 diabetes mellitus (T2DM)

Journal of Adolescent Health

Volumn 34, Issue 4, 2004, Pages 290-299

  Urrutia Rojas, Ximena ^a   Menchaca, John ^b   Wadley, Wendy ^a   Ahmad, Naveed ^a   Lacko, Andras ^a   Bae, Sejong ^a   Spellman, Craig ^a   Kudchodkar, Bhalchandra ^a   Kudolo, George ^c   McConathy, Walter ^a,d  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b Department of Metabolic Genetics   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d University of North Texas Health Science Center   (United States)

Author keywords

Acanthosis nigricans; Body mass index; Metabolic syndrome; Prediabetic

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ACANTHOSIS NIGRICANS; ANALYTIC METHOD; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HISPANIC; HUMAN; INSULIN BLOOD LEVEL; LIPID OXIDATION; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ACANTHOSIS NIGRICANS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MEXICAN AMERICANS; OBESITY; RISK FACTORS; TEXAS;

EID: 12144289112     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2003.07.005     Document Type: Article

References (41)

1. Straus R., Pallock H. Epidemic increase in childhood overweight, 1986-1998. JAMA. 286:2001;2845-2848.
2. Fagot-Campagna A., Pettitt D.J., Engelgau M.M., et al. Type 2 Diabetes among North American children and adolescents An epidemiological review and a public health perspective. J Pediatr. 136:2000;664-672.
3. Glaser N.S. Non-insulin-dependent diabetes mellitus in childhood and adolescence. Pediatr Clin North Am. 44:1997;307-337.
4. Pinhas-Hamiel O., Dolan L.M., Daniels S.R., et al. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 128:1996;608-615.
5. Martin M.M., Martin A.L.A. Obesity, hyperinsulinism, and diabetes mellitus in childhood. J Pediatr. 82:1993;192-201.
6. Rosenbloom A.L., Wheeler L., Bianchi R., et al. Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents. Diabetes. 24:1975;820-828.
7. American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics 2000;105:671-80.
8. Stuart C.A., Gilkison C.R., Smith M.M., et al. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr (Phila). 37:1998;73-79.
9. Burke J.P., Hazuda H.P., Hale D.E., Stern M.P. A quantitative scale of acanthosis nigricans. Diabetic Care. 22:1999;1655-1659.
10. Berenson G.S., Srinivasan S.R., Bao W. Precursors of cardiovascular risk in young adults from a biracial (black-white) population The Bogalusa Heart Study. Ann N Y Acad Sci. 817:1997;189-198.
11. McGill H.C. Jr, McMahan C.A. Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol. 82:1998;30T-36T.
12. Berenson G.S., Srinivasan S.R. Emergence of obesity and cardiovascular risk for coronary artery disease The Bogalusa Heart Study. Prev Cardiol. 4:2001;116-121.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285:2001;2486-2497.
14. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US Adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA. 287:2002;356-359.
15. Rosner B., Prineas R., Loggie J., Daniels S. Percentiles for body mass index in U.S. children 5 to 17 years of age. J Pediatr. 132:1998;211-222.
16. National High Blood Pressure Education Program Working Group on Hypertension Education in Children and Adolescents. Update on the 1987 Task Force on High Blood Pressure in Children and Adolescents A Working Group Report for the National High Blood Pressure Education Program. Pediatrics. 98:1996;649-657.
17. Stuart C.A., Driscoll M.S., Lundquist K.F., et al. Acanthosis nigricans. J Basic Clin Physiol Pharmacol. 9:1998;407-418.
18. Stuart C.A., Pate C.J., Peters E.J. Prevalence of acanthosis nigricans in an unselected population. Am J Med. 87:1989;269-272.
19. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
20. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
21. Kalman J., Kudchodkar B.J., Murray K., et al. Evaluation of serum-lipid-related risk factors in Alzheimer's Disease. Dement Geriatr Cogn Disord. 10:1999;488-493.
22. Furlong C.E., Richter R.J., Seidel S.L., et al. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem. 80:1989;242-247.
23. Field A.E., Coakley E.H., Must A., et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 161:2001;1581-1586.
24. Himes J.H., Dietz W.H. Guidelines for overweight in adolescent preventive services Recommendations from an expert committee. Am J Clin Nutr. 69:1994;307-316.
25. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 342:2000;836-843.
26. Tamir I., Heiss G., Glueck C.J., et al. Lipid and lipoprotein distributions in white children ages 6-19 yr. The Lipid Research Clinics Program Prevalence Study. J Chronic Dis. 34:1981;27-39.
27. Hickman T.B., Briefel R.B., Carroll M.D., et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years Data from the Third National Health and Nutrition Examination Survey. Prev Med. 27:1998;879-890.
28. Sinaiko A.R., Jacobs D.R. Jr, Steinberger J., et al. Insulin resistance syndrome in childhood Associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr. 139:2001;700-707.
29. Gower B.A. Syndrome X in children Influence of ethnicity and visceral fat. Am J Human Biol. 11:1999;249-257.
30. Chen W., Bao W., Begum S., et al. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects The Bogalusa Heart Study. Diabetes. 49:2000;1042-1048.
31. Falkner B., Michel S. Obesity and other risk factors in children. Ethn Dis. 9:1999;284-289.
32. Reaven P., Nader P.R., Berry C., Hoy T. Cardiovascular disease insulin risk in Mexican-American and Anglo-American children and mothers. Pediatrics. 101:1998;E12.
33. Chen W., Srinivasan S.R., Elkasabany A., Berenson G.S. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults The Bogalusa Heart Study. Am J Epidemiol. 150:1999;667-674.
34. Hardin D.S., Hebert J.D., Bayden T., et al. Treatment of childhood syndrome X. Pediatrics. 100:1997;E5.
35. Castelli W.P. Lipids, risk factors and ischaemic heart disease. Atherosclerosis. 124:(Suppl):1996;S1-9.
36. Yamada A., Tetsuo S., Tahara H., et al. Effect of insulin resistance on serum paraoxonase activity in nondiabetic population. Metabolism. 50:2001;805-811.
37. Clark, D. The Revised CDC/NCHS Growth Charts. Maternal and Child Nutrition Branch of CDC; 1998.
38. Leger J., Jaquet D., Levy-Marchal C., Czernichow P. Syndrome X A consequence of intra-uterine malnutrition? J Pediatr Endocrinol Metab. 13:(Supp 5):2000;1257-1259.
39. Barker D.J., Hales C.N., Fall C.H., et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X) Relation to reduced fetal growth. Diabetologia. 36:1993;62-67.
40. Williams R., Hunt S., Heiss G., et al. Usefulness of cardiovasucular family history data for population-based preventive medicine and medical research (The Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol. 87:2001;129-135.
41. Resnick H.E., Jones K., Ruotolo G., et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians. The Strong Heart Study. Diabetes Care. 26:2003;861-867.